Version 5.4
Mus musculus Protein: Ficd
Summary
InnateDB Protein IDBP-191790.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Ficd
Protein Name FIC domain containing
Synonyms
Species Mus musculus
Ensembl Protein ENSMUSP00000071719
InnateDB Gene IDBG-191788 (Ficd)
Protein Structure
UniProt Annotation
Function Adenylyltransferase that mediates the addition of adenosine 5'-monophosphate (AMP) to specific residues of target proteins. {ECO:0000250}.
Subcellular Localization Membrane {ECO:0000305}; Single-pass membrane protein {ECO:0000305}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 2 interaction(s) predicted by orthology.
Predicted by orthology
Total 2 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005515 protein binding
GO:0005524 ATP binding
GO:0070733 protein adenylyltransferase activity
Biological Process
GO:0018117 protein adenylylation
Cellular Component
GO:0005575 cellular_component
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID MGI:1098550
InterPro IPR003812 Fido domain
IPR013026 Tetratricopeptide repeat-containing domain
PFAM PF02661
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q8BIX9
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 231630
UniGene Mm.470963
RefSeq NP_001010825
MGI ID
MGI Symbol Ficd
OMIM
CCDS CCDS51620
HPRD
IMGT
EMBL AK044446 AK054325 AK087477 BC139821
GenPept AAI39822 BAC31924 BAC35731 BAC39889

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca